Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients

Abroad (travel likely)Recruiting

Conditions

Chronic Kidney Disease · Diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mona Mohamed Abdelkhalek, Cairo, Egypt
Contact: Study coordinator (Mona Mohamed Abdelkhalek, assistance prof) · 3m.sons@gmail.com · 002021024056108
Contact: Study coordinator (Mona mohamed Abdekhalek, assistance prof) · 01024056108

Study leads

Mona Mohamed Abdelkhalek
Principal Investigator
Badr University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Chronic Kidney Disease (Stages 4 and 5) · Kidney Disease · Type 2 Diabetes

Abroad (travel likely)Recruiting

Phoenix, United States

Breakthrough - T1DM and Chronic Kidney Disease

Diabete Type 1 · Chronic Kidney Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

Chronic Kidney Disease · Kidney Disease · Kidney Disease, Chronic

Abroad (travel likely)RecruitingPHASE1

Winter Park, United States

Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)

Chronic Kidney Disease on Hemodialysis

Abroad (travel likely)Recruiting

Madrid, Spain